Hepatitis C Articles A-Z
This page contains links to eMedTV Hepatitis C Articles containing information on subjects from
Fatigue With Hepatitis C Combination Therapy to HCV Combination Therapy: Who Should Not Use It?. The information is organized alphabetically; the "Favorite Articles" contains the
top articles on this page. Links in the box will take you directly to the articles; those same links are
available with a short description further down the page.
-
Fatigue With Hepatitis C Combination Therapy
-
Fatigue-- Combination Therapy Side Effects
-
Flu-like Symptoms -- Combination Therapy Side Effects
-
Flu-like Symptoms With Hepatitis C Combination Therapy
-
Following Your Hepatitis C Treatment Program
|
-
Genotype 1 and Hepatitis C Treatment
-
Getting Rid of Used Syringes (Peginterferon)
-
Giving the Pegasys Injections
-
Giving the Peginterferon Injection
-
Hapatitis C
|
-
HCV Combination Therapy: Who Should Not Use It?
|
Fatigue With Hepatitis C Combination Therapy
When taking combination therapy for hepatitis C, it's common to feel fatigue and weakness. This eMedTV resource covers this effect of combination therapy and offers tips for overcoming fatigue, like getting enough rest, exercise, and fluids.
This video explains that fatigue is a possible side effect of combination therapy.
This multimedia clip explains that flu-like symptoms are a possible side effect of combination therapy.
Flu-like Symptoms With Hepatitis C Combination Therapy
People who take combination therapy for their hepatitis C often feel like they have the flu. This part of the eMedTV library discusses these flu-like symptoms (aches, chills, headache, fever) and how to reduce this side effect of combination therapy.
Following Your Hepatitis C Treatment Program
Following your hepatitis C treatment program requires dedication, as it may take a year to clear the virus. This eMedTV page explains the role of exercise, hydration, and avoiding harmful substances in following your hepatitis C treatment program.
Genotype 1 and Hepatitis C Treatment
It's estimated that up to 50% of people with genotype 1 HCV will have a successful response to hepatitis C treatment. This eMedTV resource explores how genotype -- as well as viral load and levels of liver damage -- can impact hepatitis C treatment.
This video clip explains how to dispose of used syringes.
Giving the Pegasys Injections
It's important for Pegasys injections to be given at the same time every week. This eMedTV article offers detailed instructions for giving Pegasys injections, including how to prepare the syringe, inject the peginterferon, and dispose of needles.
This video offers helpful tips on giving yourself the injection.
Hapatitis C
Hepatitis C, which can be acute or chronic, is an infectious disease that causes liver inflammation. This eMedTV page explains how hepatitis C is spread and explores its treatment options. Hapatitis C is a common misspelling of hepatitis C.
HCV Combination Therapy: Who Should Not Use It?
This eMedTV page covers why HCV combination therapy shouldn't be taken by pregnant women or anyone with a recent history of substance abuse, suicidal thoughts, or severe depression. It also lists possible interactions for peginterferon and ribavirin.
